Across TCGA pan-cancer cohorts, MAPK6P2 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MAPK6P2’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where MAPK6P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MAPK6P2 is over-expressed in tumor.

BRCA and LUSC are the cancer types where MAPK6P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MAPK6P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	III,IV	+0.008	.049	2	view →
LUSC	All	II,III,IV	+0.010	.020	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MAPK6P2 RNA expression & survival · all MAPK6P2 data types